Twitter LinkedIn
    Thursday, August 18
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»Blueberry Therapeutics secures additional GBP3.6m Series B investment
    Deals & Transactions

    Blueberry Therapeutics secures additional GBP3.6m Series B investment

    February 17, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Drug discovery and development company, Blueberry Therapeutics, has secured a GBP3.6 million extension to its previously successful GBP10.8 million Series B fundraising.

    Japanese investor, Medical Incubator Japan (MIJ), and a private syndicate of US Board Certified Dermatologists – led by Dr Omar Ibrahimi of the Connecticut Skin Institute – have invested GBP3.1 million and GBP500k, respectively.

    BB2603 is Blueberry Therapeutics lead drug candidate and is now in Phase II of clinical development. It is designed to enhance the delivery of terbinafine – an anti-fungal medicine – under the nail and to treat infections quickly and effectively, using a smaller dose.

    The additional GBP3.6m funding will support the Phase II dose-finding study, ahead of Phase III clinical development in the US and EU for the treatment of onychomycosis.

    Read more at: Private Equity Wire

    Image Source

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    deals Investments
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Saudi Arabia’s PIF, Cain invest $900m in hotelier Aman Group

    August 17, 2022

    Denham Capital to sell Nexif Energy’s portfolio to RATCH Group in deal worth $1B

    August 17, 2022

    Nearmap shares surge as Thoma Bravo offers over $750m for Australian aerial mapping company

    August 16, 2022

    Advent to sell Bioduro stake, eyes valuation over $1B

    August 16, 2022

    Comments are closed.

    Other Articles

    Foxconn ramps up EVs push via deal with Chinese start-up

    January 5, 2021

    Macquarie Infrastructure Corporation Announces Agreement to Sell Atlantic Aviation to KKR for $4.475 Billion

    June 7, 2021

    Aviva exits Italian market with $1.1bn Allianz, CNP deal

    March 6, 2021

    Malaysian pension fund launches $600 million fund managed by BlackRock

    February 26, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?